1.
Altintas O, Altintas MO, Tasal A, Kucukdaglı OT, Asil T. The relationship of platelet-to- lymphocyte ratio with clinical outcome and final infarct core in acute ischemic stroke patients who have undergone endovascular therapy. <em>Neurol Res. </em>2016;38(9):759-765. doi:10.1080/01616412.2016.1215030
2.
Nandakumar N. Diffusion weighted imaging in acute ischemic stroke: a review of its interpretation pitfalls and advanced diffusion imaging application. J Neurol Sci. 2021;425: 117435. doi:10.1016/j.jns.2021.117435
3.
Tuttolomondo A, Puleo MG, Velardo MC, Corpora F, Daidone M. Molecular biology of atherosclerotic ischemic strokes. Int J Mol Sci. 2020;21(24): 9372. doi:10.3390/ijms21249372
4.
Staszewski J, Pogoda A, Data K, et al. The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis. <em>Clin inter aging. </em>2019;493-503. doi:10.2147/CIA.S195451
5.
Przykaza L. Understanding the connection between common stroke comorbidities, their associated inflammation, and the course of the cerebral ischemia/reperfusion cascade. <em>Front Immunol. </em>2021;12:782569. doi:10.3389/fimmu.2021.782569
6.
Stanzione R, Forte M, Cotugna M, Bianchi F, Marchitti S, Rubattu S. Role of DAMPs and of leukocytes infiltration in ischemic stroke: insights from animal models and translation to the human disease. <em>Cell Mol Neurobiol</em>. 2022;42(3):545-556 doi:10.1007/s10571-020- 00966-4
7.
Muela H, Sandala FM, Tito JAJ, et al. Neutrophil-lymphocyte ratio and coronary artery disease risk in patients undergoing coronary angiography. <em>EC Cardiology. </em>2023;10:19-27.
8.
Velioglu Y, Yuksel A. Complete blood count parameters in peripheral arterial disease. <em>The Aging Male. </em>2019;22(3):187-191. doi:10.1080/13685538.2019.1588873
9.
Tudurachi BS, Anghel L, Tudurachi A, Sascau RA, Statescu C. Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and monocyte/HDL-cholesterol ratio) in acute myocardial infarction and particularities in young patients. <em>Int J Mol Sci. </em>2023;24(18):14378. doi:10.3390/ijms241814378
10.
Cho KI, Ann SH, Singh GB, Her AY, Shin ES. Combined usefulness of the platelet-to- lymphocyte ratio and the neutrophil-to-lymphocyte ratio in predicting the long-term adverse events in patients who have undergone percutaneous coronary intervention with a drug-eluting stent. <em>PLoS One. </em>2015;10(7): e0133934. doi:10.1371/journal.pone.0133934
11.
Kotfis K, Bott-Olejnik M, Szylinska A, Rotter I. Could neutrophil-to-lymphocyte ratio (NLR) serve as a potential marker for delirium prediction in patients with acute ischemic stroke? A prospective observational study. <em>JCM</em>. 2019;8(7):1075. doi:10. 3390/jcm8071075
12.
Farah R, Nava S. Mean platelets volume and neutrophil to lymphocyte ratio as predictors of stroke. <em>J Clin Lab Anal. </em>2018; 32(1):e22189. doi:10.1002/jcla.22189
13.
Faber J, Hvas AM, Kristensen SD, Grove EL, Adelborg K. Immature platelets and risk of cardiovascular events among patients with ischemic heart disease: a systematic review. <em>Thromb Haemost. </em>2021;121(5):659-675. doi:10.1055/ s-0040-1721386
14.
Mayda-Domaç F, Mısırlı H, Yılmaz M. Prognostic role of mean platelet volume and platelet count in ischemic and hemorrhagic stroke. <em>J Stroke Cerebrovasc. </em>2010;19(1):66-72. doi:10.1016/j.jstrokecerebrovasdis.2009.03.003
15.
Lok U, Gulacti U, Ekmekci B, Bulut T, Celik M. Predictive and prognostic role of mean platelet volume in patients with first-ever acute ischemic stroke. <em>Neurosciences J. </em>2017;22(2):119-126. doi:10.17712/nsj.2017.2.20160330
16.
Mohamed AAB, Elnady HM, Alhewaig HK, Hefny HM, Khodery A. The mean platelet volume and plateletcrit as predictors of short-term outcome of acute ischemic stroke. <em>Egypt J Neurol Psychiatry Neurosurg. </em>2019;55:1-6. doi:10.1186/s41983-018-0035-x
17.
Ray B, Tinsley L, Ford L, Thompson DM, Sidorov EV, Bohnstedt BN. Trends of platelet volume index predicts delayed cerebral ischemia after subarachnoid hemorrhage. <em>World Neurosurg. </em>2018;111:e624-e631. doi:10.1016/j.wneu.2017.12.131
18.
Osadnik T, Wasilewski J, Lekston A, et al. The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation. <em>JSHA</em>. 2015;27 (3):144-151. doi:10.1016/j.jsha.2015.02.004
19.
Temiz A, Gazi E, Gungor O, et al. Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. <em>Med sci monit: İnt Med J Exp Clin Res</em>. 2014;20:660. doi:10.12659/MSM.890152
20.
Kurtul A, and Ornek E. Platelet to lymphocyte ratio in cardiovascular diseases: a systematic review. <em>Angiology</em>. 2019;70 (9):802-818. doi:10.1177/0003319719845186
21.
Liu Y, Sun W, Guo Y, et al. Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study. <em>Platelets. </em>2020;31(4):490-496. doi:10.1080/09537104.2020.1754383
22.
Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID-19. <em>J Thromb Haemost. </em>2022;18(6):1469-1472. doi:10.1111/jth.14848
23.
Lee SH, Jang MU, Kim Y, et al. The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict reperfusion and prognosis after endovascular treatment of acute ischemic stroke. <em>J. Pers. Med</em>. 2021;11(8):696. doi:10.3390/jpm11080696